Endpoints at #JPM24 | Primed to unlock biopharma's next dealmaking wave
JAN 8-9, 2024
MARRIOTT MARQUIS
780 Mission St, San Francisco, CA

An oasis has emerged in the biopharma money desert as backers look to replenish capital — still, uncertainty remains on whether it's a mirage or the much needed dealmaking bump the industry needs. Yet spirits run high as JPM24 marks the triumphant return of inking strategic alliances and peering into the industry crystal ball — while keeping an eye out for some major M&A.

We’re back live in San Francisco’s Union Square for JPM Monday and Tuesday — our calendar of can't-miss panels and fireside chats will feature prominent biopharma leaders to watch. The Endpoints Hub provides the ultimate coworking space with everything you need — 1:1 and group meeting spots plus guest pass capabilities and more. Join us in-person at the Endpoints Hub or watch online to stay plugged into all the action.

Choose your pass

SPONSORED BY

For sponsorship opportunities contact Ryan McRae

Icon

Get the inside scoop on the shifting R&D landscape from the leaders shaping biopharma's future

Icon

Join the Endpoints Hub — a home base at the center of the action in Union Square

Icon

Up your networking game with transferable guest passes for colleagues to access sessions + coworking

Icon

Can’t make it to SF? Tune in online by signing up for our livestream sessions

monday, jan 8 7:00am - 5:00pm PST

Join Endpoints on Monday as we sit down with leading minds in research, investing and deal making. Our Monday sessions will feature some of pharma’s top M&A execs, a view from the top at one of biotech’s creation engines, a candid look at the capital raising process at two up-and-coming companies, and inside perspectives from the activist and M&A world. We’ll close the day with a can’t-miss keynote interview.

The Endpoints Hub will be open for coworking & networking — power up your devices, check email and grab coffee and a bite between session.

View Monday agenda

FEATURING

Carolyn Bertozzi
Carolyn Bertozzi
Prof. of Chemistry and Baker Family Director of Sarafan
Stanford University
Marc Steinberg
Marc Steinberg
Senior Portfolio Manager
Elliott Investment Management
Mikael Dolsten
Mikael Dolsten
Chief Scientific Officer, President, Pfizer Research & Development
Pfizer
Noubar Afeyan
Noubar Afeyan
Founder & CEO / Co-Founder & Chairman
Flagship Pioneering / Moderna
Glenn Hunzinger
Glenn Hunzinger
Pharmaceutical & Life Sciences Consulting Solutions Leader
PwC US
Rachna Khosla
Rachna Khosla
SVP, Head of Business Development
Amgen
Thomas Clozel
Thomas Clozel
Co-Founder & CEO
Owkin
James Sabry
James Sabry
Global Head of Pharma Partnering
Roche
E. Eric Tokat
E. Eric Tokat
Co-President, Investment Banking
Centerview Partners
Ray Pressburger
Ray Pressburger
North America Life Sciences Industry Lead & Global Life Sciences Strategy Lead
Accenture
Venkat Sethuraman
Venkat Sethuraman
SVP, Global Biometrics & Data Sciences
Bristol Myers Squibb
Frank O. Nestle
Frank O. Nestle
Global Head of Research & Chief Scientific Officer
Sanofi
Matthias Evers
Matthias Evers
Chief Business Officer
Evotec
Andrew Dunn
Andrew Dunn
Biopharma Correspondent
Endpoints News
Kyle LaHucik
Kyle LaHucik
Senior Reporter
Endpoints News
Nicole DeFeudis
Nicole DeFeudis
Editor
Endpoints News
Arsalan Arif
Arsalan Arif
Founder & Publisher
Endpoints News
Drew Armstrong
Drew Armstrong
Executive Editor
Endpoints News
John Carroll
John Carroll
Founder & Editor
Endpoints News

TUESDAY, JAN 97:00am - 5:00pm PST

On Tuesday, you’ll hear about the intersection of two of biopharma’s most active therapeutic areas, go to biotech downturn survival school, hear from the most important companies in the business of developing, selling and paying for GLP-1 drugs, and hear predictions for how 2024 will unfold.

The Endpoints Hub will be open for a second day of coworking & networking — check out our transferable guest pass option.

View tuesday agenda

FEATURING

Rupert Vessey
Rupert Vessey
Chief Scientist & Executive Partner
Flagship Pioneering
Fiona Marshall
Fiona Marshall
President, Biomedical Research
Novartis
Carl Gordon
Carl Gordon
Managing Partner
OrbiMed Advisors
Marianne De Backer
Marianne De Backer
CEO
Vir Biotechnology
Aradhana Sarin
Aradhana Sarin
CFO & Executive Director
AstraZeneca
Lucas Dennis
Lucas Dennis
SVP, Head of Research and Development
Foundation Medicine
Eliav Barr
Eliav Barr
SVP, Head of Global Clinical Development & Chief Medical Officer
Merck
Peter Lebowitz
Peter Lebowitz
Global Head of Oncology R&D
Johnson and Johnson
JJ Kang
JJ Kang
CEO
Appia Bio
Pamela Carroll
Pamela Carroll
COO
Isomorphic Labs
Kailash Swarna
Kailash Swarna
Managing Director & Global Life Sciences Clinical Development Lead
Accenture
Lydia Ramsey Pflanzer
Lydia Ramsey Pflanzer
Deputy Editor
Endpoints News
Andrew Dunn
Andrew Dunn
Biopharma Correspondent
Endpoints News
Drew Armstrong
Drew Armstrong
Executive Editor
Endpoints News
John Carroll
John Carroll
Founder & Editor
Endpoints News

WHAT IS THE ENDPOINTS HUB?

Your home base during JPM — located in the heart of Union Square at the Marriott Marquis. Coworking areas, meeting space, coffee and light bites — buy a transferable guest pass and bring your colleagues.

COWORKING SPACE

The Endpoints Hub provides the ultimate space with everything you need for 1:1 meetings and small groups. Meet fellow readers and the Endpoints team while utilizing our coworking space — coffee, tea and light bites served throughout the day. Bring your colleagues using our guest pass ticket option.

GUEST PASSES

Need to hold a quick meeting? Get the flexibility to buy a discounted guest pass that will let you bring colleagues in and out of the Endpoints Hub. Transferable guest passes allow for different guests to rotate in and out for your meeting needs.

Register now